Editor's Summaries of the Articles Published in This Issue of Molecular Medicine Communications
DOI:
https://doi.org/10.55627/mmc.002.001.0083Abstract
In this issue, Riaz et al., carried out a pharmacological investigation of Carvacrol against D-galactose-induced cognitive impairment in mice, Fawad and Tahir reviewed the existing and emerging therapies in amyotrophic lateral sclerosis, Jahan and colleagues did a comparative analysis of the hepatoprotective potential of Co-enzyme Q10 as a preventive and therapeutic agent in statin-induced hepatotoxicity, Sheikh et al., reviewed studies with angiotensin-converting enzyme (ACE) inhibitors; their efficacy, adverse effects, and the genetic influence on ACE inhibitors induced cough.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Editorial Staff
This work is licensed under a Creative Commons Attribution 4.0 International License.